Santa Clarita, CALIFORNIA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Santa Clarita, CALIFORNIA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Santa Clarita, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
665
Enrolling

Recruiting Ankylosing Spondylitis Studies in Santa Clarita

About Ankylosing Spondylitis Clinical Trials in Santa Clarita

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Santa Clarita, CALIFORNIA. These studies are seeking a combined 665 participants. Research is being sponsored by Hoffmann-La Roche, Immunovant Sciences GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Santa Clarita — FAQ

Are there ankylosing spondylitis clinical trials in Santa Clarita?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Santa Clarita, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Clarita?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Clarita research site will contact you about next steps.

Are clinical trials in Santa Clarita free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Clarita studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Santa Clarita are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov